- GVM will use EIB financing to develop medical technologies, carry out clinical research and strengthen digital infrastructure.
- The operation is backed by InvestEU, the European Union’s investment programme.
The European Investment Bank (EIB) has announced a financing operation worth €35 million to support research, development and innovation projects at GVM, one of Italy’s leading hospital groups. The financing is backed by InvestEU, the European Union’s investment programme. The EIB Group is the programme’s main implementing partner.
The aim of the EIB’s operation is to make care more accessible and personalised, to digitalise and automate services available to patients, and to improve operational efficiency.